Lauren McBride is an Oncology Safety Evaluator at the U.S. Food and Drug Administration. In her current role, she completes pharmacovigilance reviews to evaluate post-marketing safety issues for oncology products. She received her Doctor of Pharmacy degree from the University of Rhode Island and completed her pharmacy practice residency at Boston Medical Center in Boston, MA and her oncology specialty residency at The Johns Hopkins Hospital in Baltimore, MD. Prior to joining the FDA, Dr. McBride spent most of her clinical career as a Clinical Pharmacy Practitioner in blood and marrow transplant at the Johns Hopkins Hospital where she precepted multiple students and residents and was an invited speaker for regional and national organizations. She has also worked as a Clinical Pharmacy Specialist for the National Institutes of Health and Kaiser Permanente. Dr. McBride has been an active HOPA member for over 15 years, serving as an invited participant at HOPA strategic planning meetings, an author on the HOPA Scope of Hematology/Oncology Pharmacy Practice paper, and involvement on multiple committees and task forces.